KLSE (MYR): FLEXI (0231)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.22
Today's Change
0.00 (0.00%)
Day's Change
0.22 - 0.225
Trading Volume
352,700
Market Cap
66 Million
NOSH
300 Million
Latest Quarter
31-Mar-2024 [#1]
Announcement Date
23-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
23-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
-95.92% | -92.22%
Revenue | NP to SH
32,203.000 | 234.000
RPS | P/RPS
10.75 Cent | 2.05
EPS | P/E | EY
0.08 Cent | 281.75 | 0.35%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.13 | 1.69
QoQ | YoY
-74.29% | 105.53%
NP Margin | ROE
-0.35% | 0.60%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Latest Audited Result
31-Dec-2023
Announcement Date
30-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
30-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
38,261.000 | 910.000
RPS | P/RPS
12.77 Cent | 1.72
EPS | P/E | EY
0.30 Cent | 72.45 | 1.38%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.12 | 1.78
YoY
123.51%
NP Margin | ROE
0.99% | 2.46%
F.Y. | Ann. Date
31-Dec-2023 | 29-Feb-2024
Revenue | NP to SH
18,980.000 | 228.000
RPS | P/RPS
6.33 Cent | 3.47
EPS | P/E | EY
0.08 Cent | 289.16 | 0.35%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-74.95% | -92.22%
NP Margin | ROE
1.41% | 0.59%
F.Y. | Ann. Date
31-Mar-2024 | 23-May-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 2 / 4 | 50.00% | 3 / 8 | 37.50% |
Continuous Quarters Of Positive Profit | 2 / 4 | 50.00% | 2 / 8 | 25.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 0.15% | -161.32% | ||
Average Net Profit Margin | -1.12% | -3.79% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Total Positive Profit Years | 4 / 5 | 80.00% | 4 / 5 | 80.00% |
Continuous Quarters Of Positive Profit | 1 / 5 | 20.00% | 1 / 5 | 20.00% |
Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 5 | 20.00% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 5 | 20.00% |
Total Dividend Years | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Average ROE | 1,820.33% | 1,820.33% | ||
Average Net Profit Margin | 3.45% | 3.45% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 32,203 | 18,980 | 38,261 | 67,809 | 67,809 |
NP to SH | 234 | 228 | 910 | 1,884 | 1,884 |
Dividend | 0 | 0 | 0 | 0 | 0 |
Adjusted EPS | 0.08 | 0.08 | 0.30 | 0.63 | 0.63 |
Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -45.18% | -56.08% | -56.08% | -41.06% | -62.99% |
NP to Owner | -95.92% | -92.22% | -92.22% | -2.56% | 111.42% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -95.71% | -91.82% | -91.82% | 1.19% | 112.01% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | -15.83% | -52.51% | -52.51% | -50.39% | -72.01% | -72.01% | -56.66% | -43.58% | -43.58% |
NP to Owner | -74.29% | -87.58% | -87.58% | -74.95% | -87.90% | -87.90% | 123.51% | -51.71% | -51.71% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | -73.65% | -87.28% | -87.28% | -73.65% | -87.28% | -87.28% | 123.51% | -51.71% | -51.71% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Flexidynamics ventures into gamma radiation sterilisation sector with 51pct stake acquisition of Gammatech
https://www.nst.com.my/business/corporate/2024/06/1062734/flexidynamics-ventures-gamma-radiation-sterilisation-sector-51pct
2 weeks ago
By offering gamma radiation sterilisation services, Flexidynamic aims to meet the growing demand for sterile products, leveraging its existing customer base and expanding into these broader markets.
The service are not only for gloves, but can also include industries such as pharmaceuticals, food processing, and packaging
2 weeks ago
Gamma radiation sterilisation is a highly effective method for eliminating microorganisms to ensure sterility, commonly used in the medical and pharmaceutical industries for sterilising devices, instruments and products. High-tech indeed
2 weeks ago
New technology new trend, Flexi alrdy moving a little bit today,, next week 25c??
2 weeks ago
gamma radiation sterilisation sector are gonna expand FLEXI presence, very great news
2 weeks ago
Top Glove returns to the black in 3Q on stronger glove demand 📈 https://theedgemalaysia.com/node/715933
2 weeks ago
Gamma tech is tapping into existing customer base and help FLEXI reach new markets
1 week ago
Syarikat ni jadi lebih canggih dari segi teknologi selepas ia memperoleh Gammatech
1 week ago
The acquisition of this high-tech company is a game changer for Flexidynamic
1 week ago
Yup and one of the largest glove manufacturers expects global glove demand to recover
https://www.thestar.com.my/business/business-news/2024/06/20/top-glove-expects-global-demand-recovery
1 week ago
many rumors flying around lately, if Flexi get new contract then can break 0.22 resistance
1 week ago
I guess the next chairman will be someone with extensive experience in the glove industry
5 days ago
New chairman appointed - DR TEH CHEE GHEE, also board member of ACO GROUP, LGMS & ORGABIO HOLDINGS
2 days ago
New managament definitely can help Flexi reach a new market, just queue & collect
22 hours ago
Bowmann
Wow, this Gammatech is really high tech. It uses gamma radiation for sterilization 😮😮
2 weeks ago